US Patent 8008013 Predicting and diagnosing patients with autoimmune disease
Patent 8008013 was granted and assigned to Oklahoma Medical Research Foundation on August, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+205 characters)
Article
Patent abstract
The present invention provides methods for the prediction and diagnosis of autoimmune diseases, including Systemic Lupus Erythematosus, using single nucleotide polymorphism in TNFAIP3 (A20).
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08008013 Predicting and diagnosing patients with autoimmune disease US Patent 8008013 Predicting and diagnosing patients with autoimmune disease
Infobox
Patent Number
0800801300
Patent Number
800801300
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080080130
Date of Patent
August 30, 2011
0Patent Application Number
122722650
Date Filed
November 17, 2008
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080080130
Date of Patent
August 30, 2011
0Patent Application Number
122722650
Date Filed
November 17, 2008
0Patent Primary Examiner
Edits on 8 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08008013 Predicting and diagnosing patients with autoimmune disease
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08008013
Date of patent
August 30, 2011
Patent application number
12272265
Date Filed
November 17, 2008
Patent primary examiner
Find more entities like US Patent 8008013 Predicting and diagnosing patients with autoimmune disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
